Lupin said it will address the observations within the stipulated timeframe and reaffirmed its commitment to maintaining CGMP compliance across all its facilities
Lupin receives Form 483 after USFDA inspection of Somerset unit
The Hindu Business Line·The Hindu Business Line··1 min readLimited
T
Continue reading on The Hindu Business Line
This article was sourced from The Hindu Business Line's RSS feed. Visit the original for the complete story.
Limited free access — this source offers metered access before requiring a subscription.